Jump to content

Drilldown: Medicines

Pharmacopedia is being built in public. Pages may be incomplete.About this site

Choose a table:


Medicines > classes : Antidepressant or Antiparkinsonian or Nootropic

Use the filters below to narrow your results.

generic:
classes: (Click arrow to add another value)
mechanism:
ACTH analogue; BDNF upregulator (1) · AMPA modulator; catecholaminergic (1) · AMPA receptor modulator (1) · AMPA receptor positive allosteric modulator (2) · AMPA/NMDA modulator; NGF/BDNF upregulation (1) · Central and peripheral COMT inhibitor (1) · D1/D2/D3 receptor agonist (1) · D2 agonist; D1 partial agonist (1) · D2 receptor agonist (1) · Dopamine and serotonin reuptake inhibitor; actoprotector (1) · Dopamine precursor (1) · Dopamine precursor + DOPA decarboxylase inhibitor (1) · GABAB agonist; alpha-2-delta calcium channel ligand (1) · Glutamate receptor antagonist; GABA modulator (1) · High-affinity choline uptake enhancer (2) · Irreversible non-selective MAO inhibitor (3) · Irreversible selective MAO-B inhibitor (2) · MAO-B inhibitor; sodium channel blocker; glutamate release inhibitor (1) · Melatonin receptor agonist; 5-HT2C antagonist (1) · Mu-opioid agonist; modulates glutamate AMPA receptors (1) · Muscarinic receptor antagonist (1) · Muscarinic receptor antagonist; dopamine reuptake inhibitor (1) · NMDA antagonist; dopamine releasing agent (1) · Non-selective dopamine receptor agonist (1) · Once-daily COMT inhibitor (1) · Peripheral COMT inhibitor (1) · Potent serotonin reuptake inhibitor; also NRI (1) · Prodrug of modafinil (1) · Reversible inhibitor of MAO-A (1) · Selective M1 muscarinic antagonist (1) · Selective norepinephrine reuptake inhibitor (3) · Serotonin and norepinephrine reuptake inhibitor (3) · Serotonin precursor; 5-hydroxytryptophan (1) · Serotonin reuptake inhibitor and 5-HT2A antagonist (1) · Serotonin–norepinephrine reuptake inhibition (balanced) (1) · Serotonin–norepinephrine reuptake inhibitor (2) · TrkB/BDNF'"`UNIQ--ref-00000084-QINU`"' '"`UNIQ--vote-00000085-QINU`"' (1) · Weak SRI; primarily H1/D2/alpha antagonist (1)
starting dose:
fda max:
routes:

Showing below up to 48 results in range #1 to #48.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)